Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients
Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Pathological angiogenesis is involved in the development of hepatocellular carcinoma. In patients with chronic hepatitis C (CHC), the level of angiogenic factor angiopoietin (ANGP)-2 is reported to be increased in the blood, correlating with fibrosis. In this study, we aimed to clarify whether blood ANGP-2 is useful as a biomarker for liver angioge...
Alternative Titles
Full title
Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_cde4ad49ac9b4ee299f033db292c346b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cde4ad49ac9b4ee299f033db292c346b
Other Identifiers
ISSN
1471-230X
E-ISSN
1471-230X
DOI
10.1186/s12876-021-01633-8
